What does bevacizumab contribute in metastatic cervical cancer when used in combination with a platinum doublet + pembrolizumab?
Answer from: at Academic Institution
I'm not sure how to answer the question. GOG 240 established paclitaxel/carboplatin/bevacizumab as the standard for first-line therapy for metastatic or recurrent cervical cancer.The BEATcc trial was a subsequent phase III trial for stage IVB, recurrent or metastatic cervical cancer that randomized ...
Comments
at Washington University School of Medicine Dr. @Chu gave the best and right answer
at ProMedica Toledo Hospital Indeed
at Hanjani Institute The addition of bevacizumab does not really add to...
Dr. @Chu gave the best and right answer
Indeed
The addition of bevacizumab does not really add to...